We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CFR:SIXCompagnie Financiere Richemont SA Analysis

Data as of 2026-03-09 - not real-time

$134.46

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Cullen/Frost Bankers (CFR) is trading at $134.46, which sits below its 20‑day (~$142) and 50‑day (~$139) moving averages, indicating short‑term pressure. The stock’s 30‑day volatility of ~21% and a beta near 1 suggest it moves in line with the broader market but with heightened swing potential. Technical momentum is mixed: the RSI of 35 points to oversold conditions, while the MACD histogram remains negative, signaling bearish short‑term momentum. Support at $132.14 provides a cushion, but the next resistance near $149 aligns with the 52‑week high. On the valuation side, the forward PE of 12.7 is well under the industry average of 17.4, and the price‑to‑book of 1.92 reflects a modest premium to book value. However, the discounted cash‑flow model pins a fair value around $124, implying the market is pricing in a modest premium.
Fundamentally, CFR delivered 9.5% revenue growth, a 34.5% operating margin and a 15.3% ROE, underscoring strong profitability for a regional bank. The dividend yield of 2.96% with a payout ratio under 40% and solid cash generation supports the sustainability of the payout. Analyst consensus remains “hold” with a median price target of $150, translating to roughly 12% upside from current levels. Recent earnings reports highlighted higher net interest income, reinforcing the bank’s core earnings engine. The combination of attractive dividend income, solid margins and a valuation gap to peers makes the stock a compelling income‑oriented play. Nonetheless, regulatory scrutiny typical for U.S. banks and the elevated volatility advise caution on timing any entry.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term support at $132.14
  • Oversold RSI suggesting potential bounce
  • Bearish MACD indicating continued downside risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth and strong operating margins
  • Attractive dividend yield and sustainable payout
  • Upside potential toward median target of $150

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Consistent profitability and solid ROE
  • Stable dividend income for income investors
  • Fair valuation relative to peers and industry

Key Metrics & Analysis

Financial Health

Revenue Growth9.50%
Profit Margin29.60%
P/E Ratio13.6
ROE15.31%
ROA1.23%
P/B Ratio1.9
Op. Cash Flow$274.0M
Industry P/E17.4

Technical Analysis

TrendBullish
RSI35.6
Support$132.14
Resistance$148.97
MA 20$142.20
MA 50$138.61
MA 200$130.32
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89

Valuation

Fair Value$123.57
Target Price$146.07
Upside/Downside8.63%
GradeFair
TypeBlend
Dividend Yield2.96%

Risk Assessment

Beta0.99
Volatility21.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.